The value of robot-assisted gastrectomy in the treatment of gastric cancer: a systematic review and meta-analysis
By
Lei Chen
Qian Wang
Wanbin He
Yonghong Wang
Yaping Li
Jie Dan
June 9, 2026
Clinical Scorecard: Assessing the Role of Robot-Assisted Gastrectomy in Gastric Cancer Management: A Systematic Review and Meta-Analysis
At a Glance
Category Detail
Condition Gastric Cancer Key Mechanisms Comparison of robotic gastrectomy (RG) and open gastrectomy (OG) in surgical outcomes. Target Population Patients diagnosed with gastric cancer undergoing surgical gastrectomy. Care Setting Surgical oncology centers with proficiency in robotic surgery.
Key Highlights
RG had longer operative time but less blood loss compared to OG. Patients undergoing RG experienced shorter hospital stays. RG demonstrated a lower postoperative complication rate and higher R0 resection rate. Guideline-Based Recommendations
Diagnosis
Diagnosis of gastric cancer through imaging or pathology. Management
Surgical intervention is the primary therapeutic approach, with RG as a minimally invasive option. Monitoring & Follow-up
Postoperative outcomes should include operative time, blood loss, hospital stay, and complication rates. Risks
Concerns regarding high costs, steep learning curve, and uncertain oncological outcomes of robotic surgery. Patient & Prescribing Data
Patients with gastric cancer eligible for surgical gastrectomy.
Robotic gastrectomy is a reasonable choice for proficient surgical centers, balancing invasiveness and oncological precision.
Clinical Best Practices
Adhere to PRISMA guidelines for systematic reviews. Utilize high-quality studies for comparative analysis of surgical techniques. Related Resources & Content
